Crystal skull

Rady Children's Appoints Vijay A. Patel, MD, as Director of Pediatric Complex Sinus and Skull Base Surgery Program and Professor of Otolaryngology at UC San Diego

Retrieved on:

星期二, 五月 7, 2024

University, Rady Children's Hospital, Hospital, Pediatric neurosurgery, Crystal skull, Doctor of Philosophy, Pathology, Patient, Physician, Child, Neurosurgery, SAN, Division, Head, UC, Nursing

SAN DIEGO, May 7, 2024 /PRNewswire/ -- Rady Children's Hospital-San Diego , one of the nation's top 10 pediatric health care systems, and the University of California San Diego are pleased to announce that Vijay A. Patel, MD, has been appointed as Director of the Pediatric Complex Sinus and Skull Base Surgery Program at Rady Children's Hospital and assistant professor of otolaryngology at UC San Diego School of Medicine.

Key Points:

SAN DIEGO, May 7, 2024 /PRNewswire/ -- Rady Children's Hospital-San Diego , one of the nation's top 10 pediatric health care systems, and the University of California San Diego are pleased to announce that Vijay A. Patel, MD, has been appointed as Director of the Pediatric Complex Sinus and Skull Base Surgery Program at Rady Children's Hospital and assistant professor of otolaryngology at UC San Diego School of Medicine.
Dr. Patel will lead a multidisciplinary team of physicians committed to providing comprehensive care for pediatric patients with complex sinonasal and skull base lesions.
At Rady Children's, the Pediatric Complex Sinus and Skull Base Surgery Program offers an endoscopic endonasal approach that removes or alleviates the source of the problem while minimizing damage to surrounding critical structures.
"Rady Children's Hospital-San Diego and UC San Diego have long set the standard for pediatric health care on the West Coast and beyond," said Dr. Patel.

RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation

Retrieved on:

星期五, 十二月 8, 2023

This approval was largely predicated on the successful pivotal preclinical and surgeon handling testing conducted by the company.

Key Points:

This approval was largely predicated on the successful pivotal preclinical and surgeon handling testing conducted by the company.
As part of the surgical closure process, the cranial flap is secured back into place with plates and screws.
The kerf line, however, is typically not sealed, which compromises the ability of the flap to integrate with the surrounding bone.
“We are truly excited to move this project into the clinical phase of testing,” said Brian Hess, CEO and Founder of RevBio.

BEN Adds Renowned Surgeon Dr. Richard S. Isaacs, MD as Advisor to Board of Directors

Retrieved on:

星期三, 十一月 8, 2023

Brand Engagement Network (“BEN”), an emerging provider of personalized customer engagement AI technology and human-like AI avatars, today announced the appointment of Dr. Richard S. Isaacs, MD as medical advisor to its board of directors.

Key Points:

Brand Engagement Network (“BEN”), an emerging provider of personalized customer engagement AI technology and human-like AI avatars, today announced the appointment of Dr. Richard S. Isaacs, MD as medical advisor to its board of directors.
DHC filed its Form S-4 Registration Statement with the Securities and Exchange Commission on October 17, 2023 - marking another critical milestone in BEN’s march towards its public listing on the Nasdaq Capital Market.
“We’re thrilled to welcome Dr. Isaacs, a highly influential physician leader and healthcare executive to the BEN team.
The BEN team is well-equipped to fulfill these promises, as their avatar is highly interactive and genuinely attentive, showcasing what I believe will be an unmatched level of compassion and empathy.”

NICO Awards $50,000 Grant to Better Understand the Biological Weakness of Rare Chordoma Tumors

Retrieved on:

星期四, 九月 21, 2023

INDIANAPOLIS, Sept. 21, 2023 /PRNewswire/ -- Zachary C. Gersey, MD, MS, neurosurgery resident at the University of Pittsburgh Medical Center, has been awarded a $50,000 Investigator Initiated Study (IIS) grant from NICO Corporation. The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies.

Key Points:

If we are able to further understand the drivers for chordoma recurrence, we may be able to treat recurrences better.
The technologies together enable freshly resected chordoma tissue to be harvested and immediately implanted into hosts to study the molecular characteristics of chordoma regrowth in a controlled setting.
The goal is to develop a working chordoma PDX model using tissue obtained from NICO technologies.
"The pressing need remains for better treatments for chordoma patients," said Josh Sommers, co-founder and executive director of the Chordoma Foundation .

The Op Games Launches MONOPOLY®: The Witcher Edition Based on CD PROJEKT RED's Hit Video Game Franchise

Retrieved on:

星期四, 九月 7, 2023

CARLSBAD, Calif., Sept. 7, 2023 /PRNewswire/ -- Usaopoly (The Op), the board game and puzzle publisher behind iconic licensed games and best-selling party games Telestrations®, Blank Slate™, and Hues and Cues™, today launched a fantastical version of the classic board game with MONOPOLY®: The Witcher Edition, under license from leading toy and game company Hasbro. Bringing one of the most renowned RPG franchises to the tabletop, fans can now embark on a new monster-slaying adventure featuring locations and characters straight from CD PROJEKT RED's acclaimed Witcher series of games.

Key Points:

Bringing one of the most renowned RPG franchises to the tabletop, fans can now embark on a new monster-slaying adventure featuring locations and characters straight from CD PROJEKT RED's acclaimed Witcher series of games.
In MONOPOLY®: The Witcher Edition, join the hunt for victory as players buy, sell, and trade monsters from the video game franchise including Bruxa, Crone, Leshen, and more.
"We're excited to be able to give fans a whole new way to experience The Witcher with a custom spin on one of America's favorite tabletop games."
To learn more about the game and The Op, visit www.TheOp.Games , and follow along on social ( @TheOpGames ) for more on the latest game announcements and launches.

Disney and LucasFilms Artist Steve Anderson Joins Palm Springs Air Museum's Creative Team

Retrieved on:

星期五, 八月 18, 2023

PALM SPRINGS, Calif., Aug. 17, 2023 /PRNewswire/ -- The Palm Springs Air Museum (PSAM) is pleased to announce that Disney and LucasFilms' Artist Steve Anderson is now the Official Artist for the Palm Springs Air Museum.

Key Points:

PALM SPRINGS, Calif., Aug. 17, 2023 /PRNewswire/ -- The Palm Springs Air Museum (PSAM) is pleased to announce that Disney and LucasFilms' Artist Steve Anderson is now the Official Artist for the Palm Springs Air Museum.
Mr. Anderson, who did all 11 Star Wars films, will create the official 2024 Honoree portraits for the Palm Springs Air Museum's February 10, 2024 Gala.
Steve takes the helm from aviation artist Stan Stokes as the official artist for the Palm Springs Air Museum.
Mr. Stokes has moved on to other creative endeavors, and the Palm Springs Air Museum wishes him well.

Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software

Retrieved on:

星期二, 七月 11, 2023

Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery.

Key Points:

Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery.
View the full release here: https://www.businesswire.com/news/home/20230711948261/en/
Stryker's Q Guidance System with Cranial Guidance Software includes a touchscreen monitor for control inside/outside the sterile field that provides high-performance 2D-3D visualization.
(Photo: Business Wire)
“With Cranial Guidance Software powered by Q, neurosurgeons have more surgical planning and guidance capabilities than ever before, with a special focus on biopsies and shunt placements,” said Robbie Robinson, president of Stryker’s Spine division.
“The new user interface and workflows are slick, and our staff loves the intuitive new views like 3D targeting and the new skull stripping feature.”
The Q Guidance System with Cranial Guidance Software was used at six early product surveillance sites in May 2023.

Indiana Jones and the Dial of Destiny: a thrilling farewell to Harrison Ford's greatest character

Retrieved on:

星期五, 六月 30, 2023

And I don’t mean Harrison Ford, who at 80 gives a bravura performance in what is surely his last outing as the adventurer with the leather jacket and battered hat.

Key Points:

And I don’t mean Harrison Ford, who at 80 gives a bravura performance in what is surely his last outing as the adventurer with the leather jacket and battered hat.
There is much mayhem, a mind-bending plot, friends old and new, stunning locations and an ending that may bring a tear to the eye.
Not even a neat trick of an atom bomb-resistant fridge could elevate this penultimate film to the pantheon of what went before.

Wearing it well

First, a few things need to be said, including the inclusion of some necessary spoilers (but nothing to completely ruin your enjoyment).
The vivid facial expressions that made Indy and Han Solo so beloved still flicker and sparkle throughout.
Yes, they are more hangdog but they’re still there, connecting Ford to his audience in that way he always managed in his prime.
He fares better than a frankly weird-looking Robert De Niro did in The Irishman – and the effect is generally convincing.

New faces

The pace is fast and frenetic, but perhaps a bit too Jason Bourne, particularly the chase sequence in Marrakesh.
Overall, though, Mangold’s direction is deft and true to the visual action gags that made the original films so exciting and watchable.
The appearance of an old fan favourite from the series provides a moment of unexpectedly powerful pathos at the end.

NICO Awards $40,000 Grant to Study Genetic & Biological Make-Up of Meningioma Brain Tumors

Retrieved on:

星期四, 五月 4, 2023

INDIANAPOLIS, May 4, 2023 /PRNewswire/ -- NICO Corporation, an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, has awarded a $40,000 grant to Daniel Prevedello, MD, vice chair for Academic Affairs and director of Skull Base and Pituitary Surgery Programs at the Ohio State University (OSU) Comprehensive Cancer Center. The grant supports an investigator initiated study – Circular RNA Analysis of Meningioma Invasion – aimed at providing new insight on the genetic and biological make-up of meningioma brain tumors that could ultimately guide new patient care decisions. Meningiomas are the most common form of non-malignant brain tumors that are slow-growing and form along the outermost layer of tissue that covers and protects the brain and spinal cord.

Key Points:

The grant supports an investigator initiated study – Circular RNA Analysis of Meningioma Invasion – aimed at providing new insight on the genetic and biological make-up of meningioma brain tumors that could ultimately guide new patient care decisions.
Meningiomas are the most common form of non-malignant brain tumors that are slow-growing and form along the outermost layer of tissue that covers and protects the brain and spinal cord.
Study on progression & recurrence of the most common brain tumor, meningioma, could guide new patient care decisions.
The NICO IIS grant program is dedicated to supporting novel pre-clinical and clinical research efforts related to improved patient and economic outcomes using NICO technologies.

NICO Corporation Among Early Companies to Successfully Transition to New EU MDR Requirements for Class III Medical Devices

Retrieved on:

星期四, 四月 27, 2023

Operation, Crystal skull, Certification, MDR, Publication, NICO, Neurosurgery, Patent, Patient, MIPS, III, Trauma, Safety, Medical device, EU

INDIANAPOLIS, April 27, 2023 /PRNewswire/ -- NICO Corporation, an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, announced today it is among early companies to successfully complete transition to the new European Union (EU) Medical Device Regulation (MDR). This regulation is considered to be the most comprehensive and stringent medical device regulation in the world and allows NICO to continue providing its innovative, clinically proven Class 3 medical device products to patients across Europe.

Key Points:

INDIANAPOLIS, April 27, 2023 /PRNewswire/ -- NICO Corporation , an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, announced today it is among early companies to successfully complete transition to the new European Union (EU) Medical Device Regulation (MDR).
Achieving EU MDR certification is a significant milestone for NICO that included a rigorous process demanding compliance with stricter requirements in quality management systems, manufacturing processes, product design, and clinical data monitoring.
"Our devices encompass the full range of EU classifications, including multiple EU class III products," said Jay Dittman, Vice President of Operations at NICO.
"The expectations under MDR have set a new standard for medical devices in Europe.